Literature DB >> 16483684

Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosis.

William Griffiths1, Susan Davies, Paul Gibbs, Andrew Thillainayagam, Graeme Alexander.   

Abstract

Sclerosing cholangitis due to Langerhans cell histiocytosis (LCH) is a rare cause of end-stage liver disease, seen mainly in children. Only a few adult cases have been reported worldwide. Liver transplantation may be a viable treatment option for what is otherwise an irreversible condition. We describe a 65-year-old female with LCH who developed severe sclerosing cholangitis with jaundice, intractable pruritus and peritoneal disease. She underwent orthotopic liver transplantation with complete amelioration of symptoms and remained well 14 months following her operation. Explant histology confirmed LCH involvement with an associated extensive sclerosing cholangitis. Symptomatic LCH cholangiopathy is an emerging indication for liver transplantation in adults.

Entities:  

Mesh:

Year:  2006        PMID: 16483684     DOI: 10.1016/j.jhep.2005.12.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

1.  Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature.

Authors:  Ibrahim Hatemi; Birol Baysal; Hakan Senturk; Kemal Behzatoglu; Erol Rustu Bozkurt; Gulsen Ozbay
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

2.  Adult langerhans cell histiocytosis with hepatic and pulmonary involvement.

Authors:  Bruno Araujo; Francisco Costa; Joanne Lopes; Ricardo Castro
Journal:  Case Rep Radiol       Date:  2015-04-21

3.  Severe sclerosing cholangitis after Langerhans cell histiocytosis treated by liver transplantation: An adult case report.

Authors:  Yunhua Tang; Zhiheng Zhang; Maogen Chen; Weiqiang Ju; Dongping Wang; Fei Ji; Qingqi Ren; Zhiyong Guo; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.